Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial

Medicine & Life Sciences

• Pragmatic Clinical Trials 100%
• Coronary Aneurysm 98%
• Mucocutaneous Lymph Node Syndrome 89%
• Low Molecular Weight Heparin 80%
• Warfarin 74%
• Coronary Vessels 58%
• Registries 56%
• Coronary Thrombosis 42%
• Child 30%
• Thrombosis 23%
• Confidence Intervals 18%
• Patient Preference 11%
• Incidence 9%
• Duration of Therapy 9%
• Anticoagulants 9%
• Aspirin 9%
• Hemorrhage 6%
• Safety 5%